Samyang Biopharm Corporation (KOSE: A0120G0)
Health Care · Biotechnology · KR
₩47,950.00
+3.01% today · +58.8% 1Y
Samyang Biopharm Corporation (KOSE: A0120G0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $252.24M.
Over the last twelve months the share price has gained 58.8%, trading between 23.25K and 150.90K.
A0120G0 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $252.24M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩150,900.00
- 52-week low
- ₩23,250.00
- Avg volume (3M)
- —
- Shares outstanding
- 7.44M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $263.50 | -0.55% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.67 | +0.31% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $145.57 | -0.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $547.80 | -0.05% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $824.34 | -1.16% |
| argenx SEENXTBR: ARGX | $65.85B | €867.40 | -3.84% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $135.44 | -6.64% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.